2-(Bipiperidin-1-yl)-5-(nitroaryl)-1, 3, 4-thiadiazoles: Synthesis, evaluation of in vitro leishmanicidal activity, and mechanism of action. Issue 16 (15th August 2019)
- Record Type:
- Journal Article
- Title:
- 2-(Bipiperidin-1-yl)-5-(nitroaryl)-1, 3, 4-thiadiazoles: Synthesis, evaluation of in vitro leishmanicidal activity, and mechanism of action. Issue 16 (15th August 2019)
- Main Title:
- 2-(Bipiperidin-1-yl)-5-(nitroaryl)-1, 3, 4-thiadiazoles: Synthesis, evaluation of in vitro leishmanicidal activity, and mechanism of action
- Authors:
- Mojallal-Tabatabaei, Zahra
Foroumadi, Parham
Toolabi, Mahsa
Goli, Fereshteh
Moghimi, Setareh
Kaboudanian-Ardestani, Sussan
Foroumadi, Alireza - Abstract:
- Graphical abstract: Highlights: Synthesis of six different derivatives of 5-(nitroheteroaryl)-1, 3, 4-thiadiazole. The assessment of in vitro anti-leishmanial activity. IIc andIIa were the most active compounds against L. major. The level of ROS was increased in treated cells. IIa andIIc induce apoptosis in promastigotes. Abstract: The development of novel leishmanicidal agents that are capable of being replaced by the available therapeutic options has become a priority. In the present study, the synthesis and leishmanicidal activity of a series of 5-(nitroheteroaryl-2-yl)-1, 3, 4-thiadiazole derivatives are described. All compounds appeared to be potent anti-leishmanial agents against both promastigote and amastigote forms of Leishmania major ( L. major) . Amongst the synthesized compounds, 2-([1, 4′-bipiperidin]-1′-yl)-5-(5-nitrofuran-2-yl)-1, 3, 4-thiadiazole (IIa ) and 1-(5-(1-methyl-5-nitro-1 H -imidazole-2-yl)-1, 3, 4-thiadiazol-2-yl)-4-(piperidine-1-yl) piperidine (IIc ) are the most effective. Infection index was statistically declined in the presence of all compounds. The analysis of redox-related factors revealed that exposure of L. major cells toIIa andIIc led to an increase in reactive oxygen species (ROS). Furthermore, two compounds were able to increase ROS and NO levels in infected macrophages in a dose-independent manner. In addition, we showed that these compounds induced cell death in promastigotes. Altogether, our results indicated the anti-leishmanialGraphical abstract: Highlights: Synthesis of six different derivatives of 5-(nitroheteroaryl)-1, 3, 4-thiadiazole. The assessment of in vitro anti-leishmanial activity. IIc andIIa were the most active compounds against L. major. The level of ROS was increased in treated cells. IIa andIIc induce apoptosis in promastigotes. Abstract: The development of novel leishmanicidal agents that are capable of being replaced by the available therapeutic options has become a priority. In the present study, the synthesis and leishmanicidal activity of a series of 5-(nitroheteroaryl-2-yl)-1, 3, 4-thiadiazole derivatives are described. All compounds appeared to be potent anti-leishmanial agents against both promastigote and amastigote forms of Leishmania major ( L. major) . Amongst the synthesized compounds, 2-([1, 4′-bipiperidin]-1′-yl)-5-(5-nitrofuran-2-yl)-1, 3, 4-thiadiazole (IIa ) and 1-(5-(1-methyl-5-nitro-1 H -imidazole-2-yl)-1, 3, 4-thiadiazol-2-yl)-4-(piperidine-1-yl) piperidine (IIc ) are the most effective. Infection index was statistically declined in the presence of all compounds. The analysis of redox-related factors revealed that exposure of L. major cells toIIa andIIc led to an increase in reactive oxygen species (ROS). Furthermore, two compounds were able to increase ROS and NO levels in infected macrophages in a dose-independent manner. In addition, we showed that these compounds induced cell death in promastigotes. Altogether, our results indicated the anti-leishmanial potential ofIIa andIIc is mediated by apoptosis through an imbalance in the redox system resulting in the elevation of ROS. This new class of compound seems to hold great promise for the development of new and useful anti-leishmanial agents. … (more)
- Is Part Of:
- Bioorganic & medicinal chemistry. Volume 27:Issue 16(2019)
- Journal:
- Bioorganic & medicinal chemistry
- Issue:
- Volume 27:Issue 16(2019)
- Issue Display:
- Volume 27, Issue 16 (2019)
- Year:
- 2019
- Volume:
- 27
- Issue:
- 16
- Issue Sort Value:
- 2019-0027-0016-0000
- Page Start:
- 3682
- Page End:
- 3691
- Publication Date:
- 2019-08-15
- Subjects:
- Anti-leishmanial activity -- Leishmania major -- Redox system -- 1, 3, 4-Thiadiazole
Bioorganic chemistry -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
Chemistry, Clinical -- Periodicals
Chemistry, Organic -- Periodicals
Chimie bio-organique -- Périodiques
Chimie pharmaceutique -- Périodiques
615.19 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09680896 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.bmc.2019.07.009 ↗
- Languages:
- English
- ISSNs:
- 0968-0896
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2089.325000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 11248.xml